Avid Bioservices Inc (CDMO)

[proteinspike]

I will mention that in my experience in dealing with stem cells there is a strong disconnect between the bench scientists who create the company and the business people who are responsible for marketing both the product and the brand.

The primary problem is that academics view the equities markets as another source of grant money and see little or no obligation to provide a return to investors.